Rofl.This is pretty funny. So people here have been worried about aggregates and just didn’t realize that’s what they were worried about.
Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
Rofl.This is pretty funny. So people here have been worried about aggregates and just didn’t realize that’s what they were worried about.
i read that, and i won't pretend i understand it, but i was able to grasp a portion of the idea, And will continue to follow along in the hopes it gets easier to understand, This is a very sensitive subject and may require more research and knowledge , I am glad there are a few "pioneers" leading the crusade, looking forward to the "end results" when they are presented,, Thanks ,,Based on what Jano shared above (linked), yes. That is my understanding.
Nice overview of the methods...
Size-Exclusion Chromatography for the Analysis of Protein Biotherapeutics and their Aggregates - PMC
In recent years, the use and number of biotherapeutics has increased significantly. For these largely protein-based therapies, the quantitation of aggregates is of particular concern given their potential effect on efficacy and immunogenicity. This ...pmc.ncbi.nlm.nih.gov
i read that, and i won't pretend i understand it, but i was able to grasp a portion of the idea, And will continue to follow along in the hopes it gets easier to understand, This is a very sensitive subject and may require more research and knowledge , I am glad there are a few "pioneers" leading the crusade, looking forward to the "end results" when they are presented,, Thanks ,,
And kudos to you for fleshing out exactly what and how we would test. That was the big failure I made with the endotoxin testing for oils and challenge of trying to run an R&D project over a forum.Have I missed any other questions related to filtration that we're seeking to answer with this proposed testing?
Bump out of pure respect.It's not as if Dr. Winter didn't have access to SEC, but chose to use the MFI method (and a few others) to get a handle on how many particles were present and removed from the filtered GH.
And kudos to you for fleshing out exactly what and how we would test. That was the big failure I made with the endotoxin testing for oils and challenge of trying to run an R&D project over a forum.
The method has to be properly qualified and calibrated prior to data generation. We may conclude we don't have the appropriate method to get accurate aggregate numbers. But at least everyone will learn something and we won't go down a rabbit hole needlessly this time.
Thank you.
Bump out of pure respect.
Good to know if we need a Porsche but only have access to a Yugo. No disrespect intended on the Yugo.
Flow Imaging Microscopy for Protein Particle Analysis—A Comparative Evaluation of Four Different Analytical Instruments - PMC
Flow imaging microscopy was introduced as a technique for protein particle analysis a few years ago and has strongly gained in importance ever since. The aim of the present study was a comparative evaluation of four of the most relevant flow imaging ...pmc.ncbi.nlm.nih.gov
In 2006, the first two biosimilar rhGH formulations were granted marketing authorisation in the European Union Omnitrope26zz and Valtropin27xx, based on com- parison with the reference rhGH products Genotropin and Humatrope, respectively. Both products met the criteria for regulatory approval of biosimilars containing rhGH, as stipulated by the EMA (Table 2). The clinical studies sub- mitted for regulatory approval of both products are sum- marised in Table 3.
Omnitrope is a rhGH variant produced in an Escherichia
coli(E. coli) host strain. The marketed formulation is soma- tropin Sandoz powder for solution for injection produced by API Sandoz GmbH. However, during clinical develop- ment two other formulations were also used: somatropin Sandoz powder for solution for injection produced by API Covance Biotechnology Service Inc., and somatropin Sandoz liquid produced by API Sandoz GmbH. Three sup- portive pharmacokinetic/pharmacodynamic studies in healthy volunteers, one efficacy study and one pivotal tol- erability study were submitted to obtain regulatory approval for this product (Table 3)26.
The pivotal efficacy study (EP2K-99-PhIII/EP2K- 00-PhIII-Fo)26,28 was a multi-centre, randomised, con- trolled, open-label, nine-month phase III study comparing the effects of somatropin Sandoz powder (API Covance) and the approved reference product Genotropin which is also produced in E.coli in 89 treatment-naı¨ve children
(2–14 years) with idiopathic growth hormone deficiency
(GHD).
The four primary efficacy endpoints were body height,
height standard deviation score (HSDS), HV and HVSDS.
No statistically significant differences were observed for
these efficacy parameters between both treatment groups
during the nine-month comparative period, indicating
comparable therapeutic efficacy between Genotropin and somatropin Sandoz powder (API Covance). In a sup- portive six-month follow-up trial (EP2K-00-PhIII-AQ) in the same patient group28, comparable therapeutic efficacy was also shown between somatropin Sandoz powder (API
Sandoz) and somatropin Sandoz liquid (API Sandoz).
During the primary nine-month study, almost 60% of patients treated with somatropin Sandoz powder (API Covance) developed anti-GH antibodies and all patients developed antibodies against E. coli proteins (HCPs), versus only about 2% and 0% of patients treated with Genotropin. This observation could be attributed to high concentrations of HCPs in the powder produced by API Covance, which enhance the development of anti-GH
antibodies. Therefore, additional purification steps were introduced in the manufacturing process.
Consequently, the HCP concentrations in the subsequent formulations
(somatropin Sandoz powder and somatropin Sandoz liquid
produced by API Covance) were within the range known
from other approved rhGH-containing formulations.
Indeed, in the pivotal tolerability study (EP2K- 02-PhIII-Lyo)26,28 a multi-centre, open-label phase III trial evaluating the effects of somatropin Sandoz powder
(API Sandoz) in 51 treatment-naı¨ve children with idio-
pathic GHD no anti-GH antibodies were detected after 12 months, while only one patient developed anti-HCP antibodies. Therefore, Omnitrope was considered to be comparable to Genotropin in terms of tolerability and immunogenicity, and it was granted marketing authorisa-
tion by EMA for all six therapeutic indications of the ref-erence product Genotropin (Table 3).
The problematic HCPs typically fall into the categories of enzymes such as serine protease, disulfide isomerase and phospholipase affecting the stability of the drug product, immunogenic proteins and stimulants of patient immune responses, or abundant hitchhiker proteins binding to the drug protein. Specific HCPs in the drug product may impact drug quality, formulation, biological function, or immunogenicity [40]
HCPs constitute a major group of process-related impurities in a drug product. The risks associated with HCPs are primarily immunogenicity. HCPs are complex mixtures with diverse physiochemical and immunological properties (2). Almost all HCPs carry clinical safety risks as foreign proteins due to the potential to elicit immune response in humans. In addition, some HCPs can also act as adjuvants to enhance immune response to a drug product (1, 3). Certain HCPs with proteolytic activity can also affect drug product stability and efficacy if not adequately removed or inactivated (4). HCPs have the potential to affect both the safety and efficacy aspects of a given drug product.
Sounds like you guys are on the right track.
As someone mentioned above. No matter the outcome everyone in the community will learn something from your efforts.
Later people can reference your results when this topic comes back up. If they have concerns or new ideas they can use your data to build on that by refining their own testing parameters.
@Ghoul
Have you started your fan club and monthly newsletter yet? You got some big fans at SST and especially AlexDavis. AD43 for Fan Club President?
Practical knowledge.
Different reaction to it.What's the reason for some people to report HGH #1 gives them good sleep, while HGH #2 wrecks their sleep? Considering both are sitting around near the same exact purity of lets say 98%.
What's the reason for some people to report HGH #1 gives them good sleep, while HGH #2 wrecks their sleep? Considering both are sitting around near the same exact purity of lets say 98%.
Just received a portion of my lobster order. I submitted payment on 3/4. Received tracking numbers 3/5. 2 china, 1 intl express (upgraded free; ty).
Some of the most prompt communication I've encountered with a vendor. Opened package today and was delighted. Some of the best looking believable stealth I've seen. You can tell he takes a lot of pride in his product and work, and I can really appreciate that. It really shows.
I have been notified of tracking updates and generally kept in the loop with what was happening.
This experience with the peps (reta, tirz, sema) has me now really considering a GH purchase. Also eyeing those geno pens for $160...is generic GH the same as pharma? I have my opinion on that.
Does pharma GH improve my sleep whereas generic does not? I don't know...I'd have to try it...